Cannabis
Canada’s Cannabis Boom Grows as Alcohol Consumption Declines
Canadians are spending heavily on legal cannabis, reaching 5.5 billion CAD in 2025, though growth is slowing due to market saturation and falling prices. Flower dominates sales, but extracts are rising. Governments gain significant tax revenue. Meanwhile, alcohol consumption is declining, as more Canadians shift toward legal cannabis products, especially younger consumers.
Canadians are spending billions of dollars on legal cannabis. Sales are growing, and profits are contributing to the national budget. At the same time, Canadians are drinking less and less alcohol. Canada’s fiscal year ends in March, so the latest data from the Canadian government are now available. See what the cannabis market looks like a few years after legalization.
The numbers are impressive. Canadians spent a staggering 5.5 billion Canadian dollars (CAD) on cannabis. This is over 6 percent more than the year before.
Profits are rising, but competition is driving down prices in Canada
Although profits are at record levels, the market in Canada is starting to slow. Previously, it was growing much faster. In 2023, growth reached almost 16 percent. In 2024, it was 11 percent.
Why the slowdown? The market is already saturated. This means there are many companies and shops. Shops are competing for customers. Therefore, they have to lower prices. The average retail price of cannabis has fallen by more than 1 percent in a year.
Who spends the most on cannabis?
The average Canadian adult spent $167 on cannabis in a year. However, the situation varies across the country.
Residents of the Yukon region in the north spend the most, averaging $384 per person.
They spend the least in Quebec. There, the average is only $105. Why so little? Quebec authorities have banned the sale of certain products. You won’t easily find THC gummies or vape pen cartridges there .
Extracts are catching up with hemp. What are customers buying?
The data clearly shows that classic cannabis (flower) remains the top choice. Consumers in Canada spent $3.29 billion on it. Flower accounts for nearly 60 percent of all sales.
But consumer attention is shifting to other products. The popularity of inhalable extracts is growing rapidly in Canada. These include:
vaporizer cartridges (vape pens),
hashish,
wax,
rosin (i.e. natural hot-pressed resin).
Sales of such extracts increased by almost 13 percent. Customers spent $1.7 billion on them.
Hemp beverages (up 9 percent) and oral extracts such as oils (up 7 percent) are also being purchased more frequently.
Interestingly, sales of edibles declined. Customers purchased 2 percent fewer cannabis-infused cookies and gummies.
Legalization is a plus. Billions in the state budget
Canada benefits greatly from legal cannabis. The federal and provincial governments collected $2.5 billion in taxes in one year. That’s an 11.5 percent increase.
What does this look like in practice? For every dollar a customer spends at a cannabis store, the government takes 45 cents in taxes.
Cannabis beats alcohol
Legal cannabis sales in Canada are on the rise. Meanwhile, alcohol sales are plummeting.
Alcohol sales in Canada will fall by 4.2 percent in 2024 and 2025. This is the largest such decline in over 20 years! Canadians are drinking less. The average has dropped from 8.7 to 8 standard drinks per person per week.
The data shows a clear trend. Young people and adults are more likely to forgo alcohol, choosing safe and legal cannabis products instead . December 2025 brought another record for cannabis dispensaries, with customers spending over $503 million in just one month.
__
(Featured image by Kindel Media via Pexels)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in FaktyKonopne. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
-
Cannabis2 weeks agoCanopy Growth Launches Cheaper 15g Medical Cannabis in Poland
-
Fintech41 minutes agoSwiss Fintech Sector Enters Maturity as AI and Infrastructure Take the Lead
-
Crypto1 week agoUltimate Convenience: Why Consumers Expect Instant, Secure, and Borderless Payments
-
Cannabis2 weeks agoAurora’s Electric Honeydew Debuts in Poland, But Shared Registry Raises Patient Caution



